Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
NT-proBNP Levels in HF Patients With & Without AF
Circ Heart Fail; ePub 2017 Oct 10; Kristensen, et al
Heart failure (HF) and reduced ejection fraction patients with atrial fibrillation (AF) had higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) compared to those without AF, a recent study found. However, the study also found that above a concentration of 400 pg/mL, which represented most patients in each group, NT-proBNP had similar predictive value for adverse cardiovascular (CV) outcomes, irrespective of AF status. The study included 14,737 patients with HF and reduced ejection fraction and a measurement of NT-proBNP at time of screening enrolled in either the PARADIGM-HF trial or the ATMOSPHERE trial, of whom 3,575 (24%) had AF at baseline ECG. Patients with and without AF were categorized into 5 NT-proBNP bands: <400, 400 to 999 (reference), 1,000 to 1,999, 2,000 to 2,999, and ≥3,000 pg/mL. Researchers found:
- For the primary composite outcome of CV death or HF hospitalization, event rates differed for patients with and without AF in the lowest band (<400 pg/mL; 8.2 vs 5.0 per 100 patient-years), but not for the higher bands.
- These findings were consistent whether NT-proBNP was examined as a categorical or continuous variable and before and after adjustment for other prognostic variables.
- Similar results were observed for the components of the composite outcome and all-cause mortality.
Kristensen SL, Jhund PS, Mogensen UM, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide levels in heart failure patients with and without atrial fibrillation. [Published online ahead of print October 10, 2017]. Circ Heart Fail. doi:10.1161/CIRCHEARTFAILURE.117.004409.
This Week's Must Reads
Must Reads in Cardiology
Consumption of SSBs & Risk of Mortality, Circulation; ePub 2019 Mar 18; Malik, et al
Dietary Cholesterol or Egg Consumption & CVD, JAMA; 2019 Mar 19; Zhong, Van Horn, et al
Physical Activity & Incidence of CHD & CVD in Women, JAMA Netw Open; ePub 2019 Mar 15; LaCroix, et al